01HealthAfrica
Guinea-Bissau vaccine trial receives approval, Guardian reports
The reported study would withhold a recommended hepatitis B vaccine dose from thousands of newborns.
The Guardian reports that a controversial vaccine trial in Guinea-Bissau received approval to proceed this week. The supplied excerpt says Danish researchers will withhold a recommended hepatitis B vaccine dose from thousands of newborns. It also describes the trial as promoted by Robert F Kennedy Jr.
What holds up
- ✓The Guardian explicitly reports approval for the trial to proceed.
- ✓Its excerpt identifies Danish researchers and the withholding of a recommended hepatitis B vaccine dose.
What doesn't yet
- ?The excerpt does not identify the approving authority or supply the trial protocol and ethics decision.
- ?The exact enrolment, consent arrangements and researchers' rationale are absent; the supplied article text is truncated.
Ask before you share
- →Which authorities approved the trial, and is the protocol publicly available?
- →What are the consent procedures, safeguards and scientific justification for withholding the dose?
Sources & original reporting
- [1]The Guardian · Published 9 Oct 2026 · theguardian.com